(19)

(11)

EP 4 739 695 A1

(12)

(43) Date of publication: 13.05.2026 Bulletin 2026/20 (21) Application number: 24739513.0 (22) Date of filing: 03.07.2024

(51) International Patent Classification (IPC):  C07D 487/18(2006.01) A61K 31/5517(2006.01) A61P 29/00(2006.01) (52) Cooperative Patent Classification (CPC): C07D 487/18 (86) International application number: PCT/EP2024/068730 (87) International publication number: WO 2025/008402 (09.01.2025 Gazette 2025/02)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: GE KH MA MD TN (30) Priority: 04.07.2023 EP 23183371 (71) Applicants: Sanofi 75017 Paris (FR) UCB Biopharma SRL 1070 Brussels (BE)	(72) Inventors: GRECIET, Hélène 75017 Paris (FR) MONNIER, Olivier 75017 Paris (FR) ZIRI, Isabelle 75017 Paris (FR) FLASZ, Jakub Tadeusz Slough Berkshire SL1 3WE (GB) GRAFFEO, Sabrina Raymonde Sophie 1070 Brussels (BE) ROUGEOT, Céline 1070 Brussels (BE) (74) Representative: J A Kemp LLP  80 Turnmill Street London EC1M 5QU London EC1M 5QU (GB)